|
Rigel Refuels R&D in $130M Offering
Seeking Alpha Rigel Pharmaceuticals (RIGL) is tapping public investors in a new offering to raise funds for advancing its pre-clinical pipeline, including an asthma drug carried through an early-stage trial by Pfizer (PFE) before it dumped its stake in the program … |
View full post on asthma – Google News